White paper: Integrating pharmacogenomics into the standard of care

Pharmacogenomics (PGx) can lead to better overall quality of care by making sure that medications are prescribed with the specific individual in mind, rather than guessing what may work best under the “standard of care” paradigm.

PGx helps provide a better understanding of how variations in key areas of an individual's genome may impact the efficacy of a medication, dosage considerations, and potential adverse drug reactions (ADRs). Thus, PGx has become a vital piece of the overall healthcare puzzle.

Download the whitepaper “Integrating pharmacogenomics into the standard of care” to learn more about the implementation hurdles that need to be overcome, as well as PGx tools that are readily available now.



Would you like to be contacted by a sales specialist, to discuss Thermo Fisher Scientific’s PGx products and solutions?

I would like Thermo Fisher Scientific (including its affiliates) to add me to a list to receive information about events, products, services and promotions which Thermo Fisher believes may be of interest to me via the following channels:

 

I can withdraw my consent and unsubscribe at any time by e-mailing reply@thermofisher.com

I acknowledge Thermo Fisher Scientific (including its affiliates) willl process my Personal Information according to its Privacy Policy, which includes information about my rights.